A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism

N-myc downstream-regulated gene 1 (NDRG1) is known as tumor/metastasis suppressor in a variety of cancers including pancreas, being involved in angiogenesis, cancer growth and metastasis. However, the precise molecular mechanism how NDRG1 exerts its inhibitory function in pancreatic cancer remains u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of oncology 2017-05, Vol.50 (5), p.1792-1800
Hauptverfasser: Liu, Wensheng, Zhang, Bo, Hu, Qiangsheng, Qin, Yi, Xu, Wenyan, Shi, Si, Liang, Chen, Meng, Qingcai, Xiang, Jinfeng, Liang, Dingkong, Ji, Shunrong, Liu, Jiang, Hu, Pengfei, Liu, Liang, Liu, Chen, Long, Jiang, Ni, Quanxing, Yu, Xianjun, Xu, Jin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1800
container_issue 5
container_start_page 1792
container_title International journal of oncology
container_volume 50
creator Liu, Wensheng
Zhang, Bo
Hu, Qiangsheng
Qin, Yi
Xu, Wenyan
Shi, Si
Liang, Chen
Meng, Qingcai
Xiang, Jinfeng
Liang, Dingkong
Ji, Shunrong
Liu, Jiang
Hu, Pengfei
Liu, Liang
Liu, Chen
Long, Jiang
Ni, Quanxing
Yu, Xianjun
Xu, Jin
description N-myc downstream-regulated gene 1 (NDRG1) is known as tumor/metastasis suppressor in a variety of cancers including pancreas, being involved in angiogenesis, cancer growth and metastasis. However, the precise molecular mechanism how NDRG1 exerts its inhibitory function in pancreatic cancer remains unclear. In this investigation, we demonstrated that K-Ras plays a vital role in modulating NDRG1 protein level in PDAC cancer cells in vitro, which is mediated through ERK signaling. Noteworthy, K-Ras downstream Akt/mTOR signaling is inhibited upon NDRG1 overexpression, resulting in decease of HIF1α level. Moreover, NDRG1 has a unique role in modulating cancer metabolism of pancreatic ductal adenocarcinoma (PDAC). The mechanism accounting for NDRG1 in modulating aerobic glycolysis, at least partly, relied on its regulation of glycolysis genes including GLUT1, HK2, LDHA and PDK1. Additionally, NDRG1 is shown to suppress the activity of HIF1α, which is responsible for regulation of glycolysis enzymes. The current study is the first to elucidate a unique facet of the potent tumor/metastasis suppressor NDRG1 in the regulation of PDAC glycolysis, leading to important insights into the mechanism by which NDRG1 exert inhibitory function in PDAC.
doi_str_mv 10.3892/ijo.2017.3938
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1957653268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A493945671</galeid><sourcerecordid>A493945671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-de08f19a4b2fb70f4ea782bd6e1971a1e140348720ce4b3db1f60fa8babfd8773</originalsourceid><addsrcrecordid>eNptkctrFTEUh4MotlaXbiUguJtrXjNJ3F1arUJR8LE1JJmTNpeZyZjMIPe_N0ProyBZnEP4fjnkfAg9p2THlWav4yHtGKFyxzVXD9AplZo2TDD-sPaE6qYTXJ-gJ6UcCGFtS-hjdMIUrw1np-j7Hk_wEwfrYcEp4I8Xny8pjhOe7eQz2CV63K9-sQO2PUzJ2-zjlEb7Bn9Z5zlDKTFNW_J6OPo0HLfACIt1aYhlfIoeBTsUeHZXz9C3d2-_nr9vrj5dfjjfXzVetGppeiAqUG2FY8FJEgRYqZjrO6BaUkuBCsKFkox4EI73joaOBKucdaFXUvIz9PL23TmnHyuUxRzSmqc60lDdyq7lrFN_qWs7gIlTSEu2fozFm73QXIu2k7RSu_9Q9fQwRp8mCLHe3wu8-idwA3ZYbkoa1qVuptwHm1vQ51RKhmDmHEebj4YSs9k01abZbJrNZuVf3P1qdSP0f-jf-vgvG6OYxQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1957653268</pqid></control><display><type>article</type><title>A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Liu, Wensheng ; Zhang, Bo ; Hu, Qiangsheng ; Qin, Yi ; Xu, Wenyan ; Shi, Si ; Liang, Chen ; Meng, Qingcai ; Xiang, Jinfeng ; Liang, Dingkong ; Ji, Shunrong ; Liu, Jiang ; Hu, Pengfei ; Liu, Liang ; Liu, Chen ; Long, Jiang ; Ni, Quanxing ; Yu, Xianjun ; Xu, Jin</creator><creatorcontrib>Liu, Wensheng ; Zhang, Bo ; Hu, Qiangsheng ; Qin, Yi ; Xu, Wenyan ; Shi, Si ; Liang, Chen ; Meng, Qingcai ; Xiang, Jinfeng ; Liang, Dingkong ; Ji, Shunrong ; Liu, Jiang ; Hu, Pengfei ; Liu, Liang ; Liu, Chen ; Long, Jiang ; Ni, Quanxing ; Yu, Xianjun ; Xu, Jin</creatorcontrib><description>N-myc downstream-regulated gene 1 (NDRG1) is known as tumor/metastasis suppressor in a variety of cancers including pancreas, being involved in angiogenesis, cancer growth and metastasis. However, the precise molecular mechanism how NDRG1 exerts its inhibitory function in pancreatic cancer remains unclear. In this investigation, we demonstrated that K-Ras plays a vital role in modulating NDRG1 protein level in PDAC cancer cells in vitro, which is mediated through ERK signaling. Noteworthy, K-Ras downstream Akt/mTOR signaling is inhibited upon NDRG1 overexpression, resulting in decease of HIF1α level. Moreover, NDRG1 has a unique role in modulating cancer metabolism of pancreatic ductal adenocarcinoma (PDAC). The mechanism accounting for NDRG1 in modulating aerobic glycolysis, at least partly, relied on its regulation of glycolysis genes including GLUT1, HK2, LDHA and PDK1. Additionally, NDRG1 is shown to suppress the activity of HIF1α, which is responsible for regulation of glycolysis enzymes. The current study is the first to elucidate a unique facet of the potent tumor/metastasis suppressor NDRG1 in the regulation of PDAC glycolysis, leading to important insights into the mechanism by which NDRG1 exert inhibitory function in PDAC.</description><identifier>ISSN: 1019-6439</identifier><identifier>EISSN: 1791-2423</identifier><identifier>DOI: 10.3892/ijo.2017.3938</identifier><identifier>PMID: 28350132</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Adenocarcinoma - genetics ; Adenocarcinoma - pathology ; Angiogenesis ; Biology ; Carcinoma, Pancreatic Ductal - genetics ; Carcinoma, Pancreatic Ductal - pathology ; Care and treatment ; Cell Cycle Proteins - biosynthesis ; Cell Cycle Proteins - genetics ; Cell growth ; Cell Line, Tumor ; Development and progression ; Enzymes ; Female ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genes ; Genes, Tumor Suppressor ; Genetic aspects ; Glycolysis - genetics ; Health aspects ; Humans ; Hypoxia ; Hypoxia-Inducible Factor 1, alpha Subunit - genetics ; Intracellular Signaling Peptides and Proteins - biosynthesis ; Intracellular Signaling Peptides and Proteins - genetics ; Kinases ; Male ; MAP Kinase Signaling System - genetics ; Medical prognosis ; Metabolism ; Metastasis ; Neoplasm Metastasis ; Neoplasm Proteins - genetics ; Pancreatic cancer ; Proteins ; Tumor suppressor genes</subject><ispartof>International journal of oncology, 2017-05, Vol.50 (5), p.1792-1800</ispartof><rights>COPYRIGHT 2017 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-de08f19a4b2fb70f4ea782bd6e1971a1e140348720ce4b3db1f60fa8babfd8773</citedby><cites>FETCH-LOGICAL-c458t-de08f19a4b2fb70f4ea782bd6e1971a1e140348720ce4b3db1f60fa8babfd8773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28350132$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Wensheng</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><creatorcontrib>Hu, Qiangsheng</creatorcontrib><creatorcontrib>Qin, Yi</creatorcontrib><creatorcontrib>Xu, Wenyan</creatorcontrib><creatorcontrib>Shi, Si</creatorcontrib><creatorcontrib>Liang, Chen</creatorcontrib><creatorcontrib>Meng, Qingcai</creatorcontrib><creatorcontrib>Xiang, Jinfeng</creatorcontrib><creatorcontrib>Liang, Dingkong</creatorcontrib><creatorcontrib>Ji, Shunrong</creatorcontrib><creatorcontrib>Liu, Jiang</creatorcontrib><creatorcontrib>Hu, Pengfei</creatorcontrib><creatorcontrib>Liu, Liang</creatorcontrib><creatorcontrib>Liu, Chen</creatorcontrib><creatorcontrib>Long, Jiang</creatorcontrib><creatorcontrib>Ni, Quanxing</creatorcontrib><creatorcontrib>Yu, Xianjun</creatorcontrib><creatorcontrib>Xu, Jin</creatorcontrib><title>A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism</title><title>International journal of oncology</title><addtitle>Int J Oncol</addtitle><description>N-myc downstream-regulated gene 1 (NDRG1) is known as tumor/metastasis suppressor in a variety of cancers including pancreas, being involved in angiogenesis, cancer growth and metastasis. However, the precise molecular mechanism how NDRG1 exerts its inhibitory function in pancreatic cancer remains unclear. In this investigation, we demonstrated that K-Ras plays a vital role in modulating NDRG1 protein level in PDAC cancer cells in vitro, which is mediated through ERK signaling. Noteworthy, K-Ras downstream Akt/mTOR signaling is inhibited upon NDRG1 overexpression, resulting in decease of HIF1α level. Moreover, NDRG1 has a unique role in modulating cancer metabolism of pancreatic ductal adenocarcinoma (PDAC). The mechanism accounting for NDRG1 in modulating aerobic glycolysis, at least partly, relied on its regulation of glycolysis genes including GLUT1, HK2, LDHA and PDK1. Additionally, NDRG1 is shown to suppress the activity of HIF1α, which is responsible for regulation of glycolysis enzymes. The current study is the first to elucidate a unique facet of the potent tumor/metastasis suppressor NDRG1 in the regulation of PDAC glycolysis, leading to important insights into the mechanism by which NDRG1 exert inhibitory function in PDAC.</description><subject>Adenocarcinoma - genetics</subject><subject>Adenocarcinoma - pathology</subject><subject>Angiogenesis</subject><subject>Biology</subject><subject>Carcinoma, Pancreatic Ductal - genetics</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Care and treatment</subject><subject>Cell Cycle Proteins - biosynthesis</subject><subject>Cell Cycle Proteins - genetics</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Development and progression</subject><subject>Enzymes</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genes</subject><subject>Genes, Tumor Suppressor</subject><subject>Genetic aspects</subject><subject>Glycolysis - genetics</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - genetics</subject><subject>Intracellular Signaling Peptides and Proteins - biosynthesis</subject><subject>Intracellular Signaling Peptides and Proteins - genetics</subject><subject>Kinases</subject><subject>Male</subject><subject>MAP Kinase Signaling System - genetics</subject><subject>Medical prognosis</subject><subject>Metabolism</subject><subject>Metastasis</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Proteins - genetics</subject><subject>Pancreatic cancer</subject><subject>Proteins</subject><subject>Tumor suppressor genes</subject><issn>1019-6439</issn><issn>1791-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkctrFTEUh4MotlaXbiUguJtrXjNJ3F1arUJR8LE1JJmTNpeZyZjMIPe_N0ProyBZnEP4fjnkfAg9p2THlWav4yHtGKFyxzVXD9AplZo2TDD-sPaE6qYTXJ-gJ6UcCGFtS-hjdMIUrw1np-j7Hk_wEwfrYcEp4I8Xny8pjhOe7eQz2CV63K9-sQO2PUzJ2-zjlEb7Bn9Z5zlDKTFNW_J6OPo0HLfACIt1aYhlfIoeBTsUeHZXz9C3d2-_nr9vrj5dfjjfXzVetGppeiAqUG2FY8FJEgRYqZjrO6BaUkuBCsKFkox4EI73joaOBKucdaFXUvIz9PL23TmnHyuUxRzSmqc60lDdyq7lrFN_qWs7gIlTSEu2fozFm73QXIu2k7RSu_9Q9fQwRp8mCLHe3wu8-idwA3ZYbkoa1qVuptwHm1vQ51RKhmDmHEebj4YSs9k01abZbJrNZuVf3P1qdSP0f-jf-vgvG6OYxQ</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Liu, Wensheng</creator><creator>Zhang, Bo</creator><creator>Hu, Qiangsheng</creator><creator>Qin, Yi</creator><creator>Xu, Wenyan</creator><creator>Shi, Si</creator><creator>Liang, Chen</creator><creator>Meng, Qingcai</creator><creator>Xiang, Jinfeng</creator><creator>Liang, Dingkong</creator><creator>Ji, Shunrong</creator><creator>Liu, Jiang</creator><creator>Hu, Pengfei</creator><creator>Liu, Liang</creator><creator>Liu, Chen</creator><creator>Long, Jiang</creator><creator>Ni, Quanxing</creator><creator>Yu, Xianjun</creator><creator>Xu, Jin</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170501</creationdate><title>A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism</title><author>Liu, Wensheng ; Zhang, Bo ; Hu, Qiangsheng ; Qin, Yi ; Xu, Wenyan ; Shi, Si ; Liang, Chen ; Meng, Qingcai ; Xiang, Jinfeng ; Liang, Dingkong ; Ji, Shunrong ; Liu, Jiang ; Hu, Pengfei ; Liu, Liang ; Liu, Chen ; Long, Jiang ; Ni, Quanxing ; Yu, Xianjun ; Xu, Jin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-de08f19a4b2fb70f4ea782bd6e1971a1e140348720ce4b3db1f60fa8babfd8773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Adenocarcinoma - pathology</topic><topic>Angiogenesis</topic><topic>Biology</topic><topic>Carcinoma, Pancreatic Ductal - genetics</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Care and treatment</topic><topic>Cell Cycle Proteins - biosynthesis</topic><topic>Cell Cycle Proteins - genetics</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Development and progression</topic><topic>Enzymes</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genes</topic><topic>Genes, Tumor Suppressor</topic><topic>Genetic aspects</topic><topic>Glycolysis - genetics</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - genetics</topic><topic>Intracellular Signaling Peptides and Proteins - biosynthesis</topic><topic>Intracellular Signaling Peptides and Proteins - genetics</topic><topic>Kinases</topic><topic>Male</topic><topic>MAP Kinase Signaling System - genetics</topic><topic>Medical prognosis</topic><topic>Metabolism</topic><topic>Metastasis</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Proteins - genetics</topic><topic>Pancreatic cancer</topic><topic>Proteins</topic><topic>Tumor suppressor genes</topic><toplevel>online_resources</toplevel><creatorcontrib>Liu, Wensheng</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><creatorcontrib>Hu, Qiangsheng</creatorcontrib><creatorcontrib>Qin, Yi</creatorcontrib><creatorcontrib>Xu, Wenyan</creatorcontrib><creatorcontrib>Shi, Si</creatorcontrib><creatorcontrib>Liang, Chen</creatorcontrib><creatorcontrib>Meng, Qingcai</creatorcontrib><creatorcontrib>Xiang, Jinfeng</creatorcontrib><creatorcontrib>Liang, Dingkong</creatorcontrib><creatorcontrib>Ji, Shunrong</creatorcontrib><creatorcontrib>Liu, Jiang</creatorcontrib><creatorcontrib>Hu, Pengfei</creatorcontrib><creatorcontrib>Liu, Liang</creatorcontrib><creatorcontrib>Liu, Chen</creatorcontrib><creatorcontrib>Long, Jiang</creatorcontrib><creatorcontrib>Ni, Quanxing</creatorcontrib><creatorcontrib>Yu, Xianjun</creatorcontrib><creatorcontrib>Xu, Jin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Wensheng</au><au>Zhang, Bo</au><au>Hu, Qiangsheng</au><au>Qin, Yi</au><au>Xu, Wenyan</au><au>Shi, Si</au><au>Liang, Chen</au><au>Meng, Qingcai</au><au>Xiang, Jinfeng</au><au>Liang, Dingkong</au><au>Ji, Shunrong</au><au>Liu, Jiang</au><au>Hu, Pengfei</au><au>Liu, Liang</au><au>Liu, Chen</au><au>Long, Jiang</au><au>Ni, Quanxing</au><au>Yu, Xianjun</au><au>Xu, Jin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism</atitle><jtitle>International journal of oncology</jtitle><addtitle>Int J Oncol</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>50</volume><issue>5</issue><spage>1792</spage><epage>1800</epage><pages>1792-1800</pages><issn>1019-6439</issn><eissn>1791-2423</eissn><abstract>N-myc downstream-regulated gene 1 (NDRG1) is known as tumor/metastasis suppressor in a variety of cancers including pancreas, being involved in angiogenesis, cancer growth and metastasis. However, the precise molecular mechanism how NDRG1 exerts its inhibitory function in pancreatic cancer remains unclear. In this investigation, we demonstrated that K-Ras plays a vital role in modulating NDRG1 protein level in PDAC cancer cells in vitro, which is mediated through ERK signaling. Noteworthy, K-Ras downstream Akt/mTOR signaling is inhibited upon NDRG1 overexpression, resulting in decease of HIF1α level. Moreover, NDRG1 has a unique role in modulating cancer metabolism of pancreatic ductal adenocarcinoma (PDAC). The mechanism accounting for NDRG1 in modulating aerobic glycolysis, at least partly, relied on its regulation of glycolysis genes including GLUT1, HK2, LDHA and PDK1. Additionally, NDRG1 is shown to suppress the activity of HIF1α, which is responsible for regulation of glycolysis enzymes. The current study is the first to elucidate a unique facet of the potent tumor/metastasis suppressor NDRG1 in the regulation of PDAC glycolysis, leading to important insights into the mechanism by which NDRG1 exert inhibitory function in PDAC.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>28350132</pmid><doi>10.3892/ijo.2017.3938</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1019-6439
ispartof International journal of oncology, 2017-05, Vol.50 (5), p.1792-1800
issn 1019-6439
1791-2423
language eng
recordid cdi_proquest_journals_1957653268
source Spandidos Publications Journals; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adenocarcinoma - genetics
Adenocarcinoma - pathology
Angiogenesis
Biology
Carcinoma, Pancreatic Ductal - genetics
Carcinoma, Pancreatic Ductal - pathology
Care and treatment
Cell Cycle Proteins - biosynthesis
Cell Cycle Proteins - genetics
Cell growth
Cell Line, Tumor
Development and progression
Enzymes
Female
Gene expression
Gene Expression Regulation, Neoplastic
Genes
Genes, Tumor Suppressor
Genetic aspects
Glycolysis - genetics
Health aspects
Humans
Hypoxia
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
Intracellular Signaling Peptides and Proteins - biosynthesis
Intracellular Signaling Peptides and Proteins - genetics
Kinases
Male
MAP Kinase Signaling System - genetics
Medical prognosis
Metabolism
Metastasis
Neoplasm Metastasis
Neoplasm Proteins - genetics
Pancreatic cancer
Proteins
Tumor suppressor genes
title A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A06%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20new%20facet%20of%20NDRG1%20in%20pancreatic%20ductal%20adenocarcinoma:%20Suppression%20of%20glycolytic%20metabolism&rft.jtitle=International%20journal%20of%20oncology&rft.au=Liu,%20Wensheng&rft.date=2017-05-01&rft.volume=50&rft.issue=5&rft.spage=1792&rft.epage=1800&rft.pages=1792-1800&rft.issn=1019-6439&rft.eissn=1791-2423&rft_id=info:doi/10.3892/ijo.2017.3938&rft_dat=%3Cgale_proqu%3EA493945671%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1957653268&rft_id=info:pmid/28350132&rft_galeid=A493945671&rfr_iscdi=true